Isomorphic Labs' $2.1bn raise is a bet that DeepMind's Nobel Prize-winning science can become a pharmaceutical business
The Alphabet spinout has never dosed a patient, has pushed clinical trials back by a year, and is now valued at roughly $10 billion, a premium that rests on the conviction that AI will compress the $2 billion, decade-long drug development process into something dramatically faster and cheaper
Business
Kraken's parent company and Franklin Templeton just made the strongest case yet that tokenised finance is moving from crypto experiment to institutional infrastructure
The partnership between a $1.7 trillion asset manager and the company behind one of the world's largest crypto exchanges aims to put professionally managed funds on blockchain rails, a step that would have been unthinkable three years ago
Tech
Commerce Department removes AI security test details
The U.S. Department of Commerce deleted a webpage describing a deal to let the government test artificial intelligence models from Google, xAI and Microsoft before public release.
Fintech
Kraken's parent company and Franklin Templeton just made the strongest case yet that tokenised finance is moving from crypto experiment to institutional infrastructure
The partnership between a $1.7 trillion asset manager and the company behind one of the world's largest crypto exchanges aims to put professionally managed funds on blockchain rails, a step that would have been unthinkable three years ago
Entertainment
Bluey joins Apple Arcade playdate across multiple games
Bluey will appear in a series of exclusive playdate events across Apple Arcade titles, the company said in an announcement.
Sport
Prediction markets are booming, but a regulatory battle over sports betting could cut them in half
Crypto's loss has been prediction markets' gain. Now the platforms that thrived by moving fast face the same regulatory reckoning that caught crypto out
Wellness
Hims & Hers revenue grew to $2.35 billion in 2025, but subs were fewer than the market hoped for
Subscribers - who repeat orders for weight loss and/or ED treatments (among others) on a recurring schedule - grew by 13%, to exceed 2.5 million.
